Oscar Health, Inc. logo OSCR - Oscar Health, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $18.75 DETAILS
HIGH: $21.00
LOW: $16.00
MEDIAN: $19.00
CONSENSUS: $18.75
DOWNSIDE: 17.18%

Stock News

Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For

Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For

Oscar Health (OSCR) delivered a standout Q1 2026, with $4.65B revenue, 52.7% YoY growth, and a 70.5% medical loss ratio. I reaffirm my Strong Buy rating and raise the 2026 price target to $30, citing robust execution and guidance reaffirmation. OSCR's SG&A leverage and technology platform drove operating efficiency, with Q1 Adjusted EBITDA at $727.1M and SG&A ratio likely below 15.8%.

May 06, 2026 05:00 AM seekingalpha.com
Meet Lucie. A New Way to Shop for Healthcare.

Meet Lucie. A New Way to Shop for Healthcare.

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (NYSE: OSCR) today launched Lucie Health Marketplace, a new all-in-one storefront that begins to change how America shops for healthcare. Lucie connects consumers and brokers to every major individual market plan and a curated menu of ancillary and supplemental products. Consumers buy cars, homes, and everyday products with transparency and choice. Healthcare is next. Lucie's platform can serve millions of entrepreneurs, full- and part-time employee.

Apr 20, 2026 02:00 AM businesswire.com

Price Targets